Table II.
Adverse events | Placebo group N = 110 | NAC group N = 102 | P-value |
---|---|---|---|
Death (all causes): | 2 (1.8%) | 4 (3.9%) | NS |
CV | 1 (0.9%) | 1 (0.9%) | NS |
Other | 1 (0.9%) | 3 (2.6%) | NS |
MI | 2 (1.8%) | 3 (2.6%) | NS |
Dialysis | 1 (0.9%) | 0 (0%) | NS |
Rehospitalization (cardiac causes) | 20 (18.1%) | 16 (15.7%) | NS |
Rehospitalization (renal causes) | 3 (2.7%) | 2 (2.0%) | NS |
NAC – N-acetylcysteine, CV – cardiovascular, MI – myocardial infarction.